Allenex to sell its holding in AnaMar AB to Koncentra Holding

Jun 3 2013NewsGuard 100/100 Score

Allenex (STO:ALNX) has agreed to sell its holding in AnaMar AB to the company's main owner Koncentra Holding. The price is set to 1,7 mkr. Allenex became an owner in AnaMar 1998. Their focus area is chronic joint diseases. Allenex has not participated in the financing of AnaMar in recent years and the equity that now is being sold equal about 2,1 % of the total share capital in AnaMar. The Allenex book value of this equity is zero. The deal will therefore mean corresponding revenue for Allenex in the second quarter of 2013. The sale will be finished in June.

"By selling our remaining holding in AnaMar, we have now divested all holdings in life science research companies. The transformation of Allenex into an operational company within transplantation diagnostics is thereby fully implemented", says Allenex CEO Anders Karlsson in a comment.

Source:

Allenex

Posted in: Business / Finance

Tags: , , , , ,

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback